StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3016% below fair value
$5.27−0.07 (-1.31%)

Close on Nov 13, 2026Market cap $342.73MP/E –Yield –

Treace Medical Concepts operating margin

Operating margin is operating income as a percentage of revenue.

Treace Medical Concepts's operating margin for the twelve months ending Sep 30, 2026 was -24.4%. For fiscal 2025 it was -25.5%, against -26.6% the year before. The highest annual figure on record is 1.5% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-25.5%+1.1
FY2024Dec 31, 2024-26.6%+0.9
FY2023Dec 31, 2023-27.5%−2.9
FY2022Dec 31, 2022-24.6%−7.1
FY2021Dec 31, 2021-17.5%−19.0
FY2020Dec 31, 20201.5%+10.5
FY2019Dec 31, 2019-9.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-23.9%+7.3
Q2 FY2026Jun 30, 2026-33.0%+2.9
Q1 FY2026Mar 31, 2026-36.4%−6.7
Q4 FY2025Dec 31, 2025-9.5%−9.2
Q3 FY2025Sep 30, 2025-31.2%+2.3
Q2 FY2025Jun 30, 2025-35.8%+12.3
Q1 FY2025Mar 31, 2025-29.6%+7.5
Q4 FY2024Dec 31, 2024-0.3%+10.6
Q3 FY2024Sep 30, 2024-33.6%+10.1
Q2 FY2024Jun 30, 2024-48.1%−17.0
Q1 FY2024Mar 31, 2024-37.1%−4.5
Q4 FY2023Dec 31, 2023-10.9%−3.9
Q3 FY2023Sep 30, 2023-43.7%−9.5
Q2 FY2023Jun 30, 2023-31.1%+8.7
Q1 FY2023Mar 31, 2023-32.6%−4.8
Q4 FY2022Dec 31, 2022-7.0%+9.7
Q3 FY2022Sep 30, 2022-34.2%−9.0
Q2 FY2022Jun 30, 2022-39.8%−20.2
Q1 FY2022Mar 31, 2022-27.9%−20.4
Q4 FY2021Dec 31, 2021-16.7%−31.8
Q3 FY2021Sep 30, 2021-25.3%−24.8
Q2 FY2021Jun 30, 2021-19.6%+0.0
Q1 FY2021Mar 31, 2021-7.5%+3.2
Q4 FY2020Dec 31, 202015.1%–
Q3 FY2020Sep 30, 2020-0.4%–
Q2 FY2020Jun 30, 2020-19.6%–
Q1 FY2020Mar 31, 2020-10.7%–

More Treace Medical Concepts figures

See a number that looks wrong?